Abstract
Nanomaterials are advancing in several directions with significant progress being achieved with respect to their synthesis, functionalization and biomedical application. In this review, we will describe several classes of prototypical nanocarriers, such as liposomes, silicon particles, and gold nanoshells, in terms of their individual function as well as their synergistic use. Active and passive targeting, photothermal ablation, and drug controlled release constitute some of the crucial functions identified to achieve a medical purpose. Current limitations in targeting, slow clearance, and systemic as well as local toxicity are addressed in reference to the recent studies that attempted to comprehend and solve these issues. The demand for a more sophisticated understanding of the impact of nanomaterials on the body and of their potential immune response underlies this discussion. Combined components are then discussed in the setting of multifunctional nanocarriers, a class of drug delivery systems we envisioned, proposed, and evolved in the last 5 years. In particular, our third generation of nanocarriers, the multistage vectors, usher in the new field of nanomedicine by combining several components onto multifunctional nanocarriers characterized by emerging properties and able to achieve synergistic effects.
Article PDF
Similar content being viewed by others
References
Sanvicens N, Marco M P. Multifunctional nanoparticles—properties and prospects for their use in human medicine. Trends Biotechnol, 2008, 26: 425–433
Babincova M, Altanerova V, Altaner C, et al. In vivo heating of magnetic nanoparticles in alternating magnetic field. Med Phys, 2004, 31: 2219–2221
Pastan I, Hassan R, Fitzgerald D J, et al. Immunotoxin therapy of cancer. Nat Rev Cancer, 2006, 6: 559–565
O’Brien M E, Wigler N, Inbar M, et al. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin hcl (caelyx/doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol, 2004, 15: 440–449
Melancon M P, Lu W, Yang Z, et al. In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy. Mol Cancer Ther, 2008, 7: 1730–1739
Ghaghada K B, Ravoori M, Sabapathy D, et al. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One, 2009, 4: e7628
Tang F, Li L, Chen D. Mesoporous silica nanoparticles: Synthesis, biocompatibility and drug delivery. Adv Mater, 2012, 24: 1504–1534
Qian K K, Bogner R H. Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems. J Pharm Sci, 2012, 101: 444–463
Chiappini C, Tasciotti E, Fakhoury J, et al. Tailored porous silicon microparticles: Fabrication and properties. Chem Phys Chem, 2010, doi: 10.1002/cphc.200900914
Longmire M, Choyke P L, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: Considerations and caveats. Nanomedicine (Lond), 2008, 3: 703–717
Musacchio T, Torchilin V P. Recent developments in lipid-based pharmaceutical nanocarriers. Front Biosci: A J Virtual Libr, 2011, 16: 1388–1412
van Vlerken L E, Amiji M M. Multi-functional polymeric nano-particles for tumour-targeted drug delivery. Expert Opin Drug Deliv, 2006, 3: 205–216
Wu S H, Hung Y, Mou C Y. Mesoporous silica nanoparticles as nanocarriers. Chem Commun (Camb), 2011, 47: 9972–9985
Du Y Z, Cai L L, Li J, et al. Receptor-mediated gene delivery by folic acid-modified stearic acid-grafted chitosan micelles. Int J Nanomed, 2011, 6: 1559–1568
Shin H C, Alani A W, Cho H, et al. A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs. Mol Pharm, 2011, 8: 1257–1265
Thierry B, Al-Ejeh F, Brown M P, et al. Immunotargeting of functional nanoparticles for MRI detection of apoptotic tumor cells. Adv Mater, 2009, 21: 541–545
Jing Y, Zhu Y, Yang X, et al. Ultrasound-triggered smart drug release from multifunctional core-shell capsules one-step fabricated by coaxial electrospray method. Langmuir, 2011, 27: 1175–1180
Muhammad F, Guo M, Qi W, et al. Ph-triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dis-solution of zno nanolids. J Am Chem Soc, 2011, 133: 8778–8781
Letfullin R R, Iversen C B, George T F. Modeling nanophotothermal therapy: Kinetics of thermal ablation of healthy and cancerous cell organelles and gold nanoparticles. Nanomedicine, 2011, 7: 137–145
Stern J M, Stanfield J, Kabbani W, et al. Selective prostate cancer thermal ablation with laser activated gold nanoshells. J Urol, 2008, 179: 748–753
Hedlund A, Ahren M, Gustafsson H, et al. Gd(2)o(3) nanoparticles in hematopoietic cells for MRI contrast enhancement. Int J Nanomed, 2011, 6: 3233–3240
Toth E, Bolskar R D, Borel A, et al. Water-soluble gadofullerenes: Toward high-relaxivity, pH-responsive MRI contrast agents. J Am Chem Soc, 2005, 127: 799–805
Hasenpusch G, Geiger J, Wagner K, et al. Magnetized aerosols comprising superparamagnetic iron oxide nanoparticles improve targeted drug and gene delivery to the lung. Pharm Res, 2012, doi: http://dx.doi.org/10.1007/s11095-012-0682-z
Yigit M V, Moore A, Medarova Z. Magnetic nanoparticles for cancer diagnosis and therapy. Pharm Res, 2012, doi: http://dx.doi.org/10.10.1007/s11095-012-0679-7
Wang X, Li J, Wang Y, et al. Hft-t, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors. ACS Nano, 2009, 3: 3165–3174
Moghimi S M, Hunter A C, Murray J C. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev, 2001, 53: 283–318
Howard M D, Jay M, Dziubla T D, et al. Pegylation of nanocarrier drug delivery systems: State of the art. J Biomed Nanotechnol, 2008, 4: 133–148
Linkov I, Satterstrom F K, Corey L M. Nanotoxicology and nanomedicine: Making hard decisions. Nanomedicine, 2008, 4: 167–171
Nel A, Xia T, Madler L, et al. Toxic potential of materials at the nanolevel. Science, 2006, 311: 622–627
Suh W H, Suslick K S, Stucky G D, et al. Nanotechnology, nanotoxicology, and neuroscience. Prog Neurobiol, 2009, 87: 133–170
Godin B, Tasciotti E, Liu X, et al. Multistage nanovectors: From concept to novel imaging contrast agents and therapeutics. ACC Chem Res, 2011, 44: 979–989
Sakamoto J H, van de Ven A L, Godin B, et al. Enabling individualized therapy through nanotechnology. Pharmacol Res, 2010, 62: 57–89
Godin B, Serda R E, Sakamoto J, et al. Nanoparticles for cancer detection and therapy. Nanotechnology. New York: Wiley-VCH Verlag GmbH & Co. KGaA, 2010
Riehemann K, Schneider S W, Luger T A, et al. Nanomedicine—challenge and perspectives. Angew Chem Int Edi, 2009, 48: 872–897
Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol, 2001, 19: 316–317
Huang X, Jain P K, El-Sayed I H, et al. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci, 2008, 23: 217–228
West J L, Halas N J. Engineered nanomaterials for biophotonics applications: Improving sensing, imaging, and therapeutics. Annu Rev Biomed Eng, 2003, 5: 285–292
Hirsch L R, Gobin A M, Lowery A R, et al. Metal nanoshells. Ann Biomed Eng, 2006, 34: 15–22
Hirsch L R, Stafford R J, Bankson J A, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA, 2003, 100: 13549–13554
O’Neal D P, Hirsch L R, Halas N J, et al. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett, 2004, 209: 171–176
Gobin A M, Lee M H, Halas N J, et al. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett, 2007, 7: 1929–1934
Loo C, Lin A, Hirsch L, et al. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat, 2004, 3: 33–40
Loo C, Lowery A, Halas N, et al. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett, 2005, 5: 709–711
Tam F, Goodrich G P, Johnson B R, et al. Plasmonic enhancement of molecular fluorescence. Nano Lett, 2007, 7: 496–501
Bardhan R, Grady N K, Halas N J. Nanoscale control of near-infrared fluorescence enhancement using Au nanoshells. Small, 2008, 4: 1716–1722
Bardhan R, Grady N K, Cole J R, et al. Fluorescence enhancement by Au nanostructures: Nanoshells and nanorods. ACS Nano, 2009, 3: 744–752
Bardhan R, Chen W X, Perez-Torres C, et al. Nanoshells with targeted simultaneous enhancement of magnetic and optical imaging and photothermal therapeutic response. Adv Funct Mater, 2009, 19: 3901–3909
Schwartzberg A M, Olson T Y, Talley C E, et al. Synthesis, characterization, and tunable optical properties of hollow gold nanospheres. J Phys Chem B, 2006, 110: 19935–19944
Lu W, Xiong C, Zhang G, et al. Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres. Clin Cancer Res, 2009, 15: 876–886
You J, Shao R, Wei X, et al. Near-infrared light triggers release of paclitaxel from biodegradable microspheres: Photothermal effect and enhanced antitumor activity. Small, 2010, 6: 1022–1031
You J, Zhang G, Li C. Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release. ACS Nano, 2010, 4: 1033–1041
Souza G R, Christianson D R, Staquicini F I, et al. Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents. Proc Natl Acad Sci USA, 2006, 103: 1215–1220
Souza G R, Staquicini F I, Christianson D R, et al. Combinatorial targeting and nanotechnology applications. Biomed Microdevices, 2010, 12: 597–606
Sengupta S, Eavarone D, Capila I, et al. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature, 2005, 436: 568–572
Ashley C E, Carnes E C, Phillips G K, et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat Mater, 2011, 10: 389–397
Irvine D J. Drug delivery: One nanoparticle, one kill. Nat Mater, 2011, 10: 342–343
Doshi N, Zahr A S, Bhaskar S, et al. Red blood cell-mimicking synthetic biomaterial particles. Proc Natl Acad Sci USA, 2009, 106: 21495–21499
Merkel T J, Jones S W, Herlihy K P, et al. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc Natl Acad Sci USA, 2011, 108: 586–591
Hu C M, Zhang L, Aryal S, et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci USA, 2011, 108: 10980–10985
Wong C, Stylianopoulos T, Cui J, et al. Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci USA, 2011, 108: 2426–2431
von Maltzahn G, Park J H, Lin K Y, et al. Nanoparticles that communicate in vivo to amplify tumour targeting. Nat Mater, 2011, 10: 545–552
Tasciotti E, Liu X, Bhavane R, et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol, 2008, 3: 151–157
Sakamoto J, Annapragada A, Decuzzi P, et al. Antibiological barrier nanovector technology for cancer applications. Expert Opin Drug Deliv, 2007, 4: 359–369
Bayliss S C, Heald R, Fletcher D I, et al. The culture of mammalian cells on nanostructured silicon. Adv Mater, 1999, 11: 318–321
Chin V, Collins B E, Sailor M J, et al. Compatibility of primary hepatocytes with oxidized nanoporous silicon. Adv Mater, 2001, 13: 1877–1880
Canham L. Bioactive silicon structure fabrication through nanoetching techniques. Adv Mater, 1995, 7: 1033–1037
Canham L, Reeves C L, Newey J, et al. Derivatized mesoporous silicon with dramatically improved stability in simulated human blood plasma. Adv Mater, 1999, 11: 1505–1507
Decuzzi P, Lee S, Decuzzi M, et al. Adhesion of microfabricated particles on vascular endothelium: A parametric analysis. Ann Biomed Eng, 2004, 32: 793–802
Decuzzi P, Ferrari M. The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials, 2006, 27: 5307–5314
Gentile F, Curcio A, Indolfi C, et al. The margination propensity of spherical particles for vascular targeting in the microcirculation. J Nanobiotechnol, 2008, 6: 9
Gentile F, Chiappini C, Fine D, et al. The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows. J Biomech, 2008, 41: 2312–2318
Gentile F, Ferrari M, Decuzzi P. The transport of nanoparticles in blood vessels: The effect of vessel permeability and blood rheology. Ann Biomed Eng, 2008, 36: 254–261
Lee S Y, Ferrari M, Decuzzi P. Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology, 2009, 20: 495101
Lee S Y, Ferrari M, Decuzzi P. Design of bio-mimetic particles with enhanced vascular interaction. J Biomech, 2009, 42: 1885–1890
Ananta J S, Godin B, Sethi R, et al. Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances t1 contrast. Nat Nanotechnol, 2010, 5: 815–821
Tanaka T, Mangala L S, Vivas-Mejia P E, et al. Sustained sirna delivery by mesoporous silicon particles for cancer treatment. Cancer Res, 2010, 70: 3687–3696
Serda R E, Mack A, Pulikkathara M, et al. Cellular association and assembly of a multistage delivery system. Small, 2010, 6: 1329–1340
Serda R E, Mack A, van de Ven A L, et al. Logic-embedded vectors for intracellular partitioning, endosomal escape, and exocytosis of nanoparticles. Small, 2010, 6: 2691–2700
Serda R E, Ferrati S, Godin B, et al. Mitotic trafficking of silicon microparticles. Nanoscale, 2009, 1: 250–259
Shen H, You J, Zhang G, et al. Cooperative, nanoparticle-enabled thermal therapy of breast cancer. Adv Healthc Mater, 2012, 1: 84–89
Tanaka T, Mangala L S, Vivas-Mejia P E, et al. Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res, 2010, 70: 3687–3696
Godin B, Gu J, Serda R E, et al. Tailoring the degradation kinetics of mesoporous silicon structures through pegylation. J Biomed Mater Res A, 2010, 94: 1236–1243
Tasciotti E, Godin B, Martinez J O, et al. Near-infrared imaging method for the in vivo assessment of the biodistribution of nanoporous silicon particles. Mol Imaging, 2011, 10: 56–68
Tanaka T, Godin B, Bhavane R, et al. In vivo evaluation of safety of nanoporous silicon carriers following single and multiple dose intravenous administrations in mice. Int J Pharm, 2010, 402: 190–197
Decuzzi P, Godin B, Tanaka T, et al. Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release, 2010, 141: 320–327
van de Ven A L, Kim P, Haley O, et al. Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. J Control Release, 2011, doi: http://dx.doi.org/10.1016/j.jconrel.2011.10.021
Mann A P, Tanaka T, Somasunderam A, et al. E-selectin-targeted porous silicon particle for nanoparticle delivery to the bone marrow. Adv Mater, 2011, 23: H278–H282
De Rosa E, Chiappini C, Fan D, et al. Agarose surface coating influences intracellular accumulation and enhances payload stability of a nano-delivery system. Pharm Res, 2011, 28: 1520–1530
Fan D, De Rosa E, Murphy M B, et al. Mesoporous silicon-PLGA composite microspheres for the double controlled release of biomolecules for orthopedic tissue engineering. Adv Funct Mater, 2012, 22: 282–293
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work.
This article is published with open access at Springerlink.com
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Martinez, J.O., Brown, B.S., Quattrocchi, N. et al. Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications. Chin. Sci. Bull. 57, 3961–3971 (2012). https://doi.org/10.1007/s11434-012-5387-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11434-012-5387-5